About this trial
Acute intermittent hypoxia (AIH) involves brief (1 min), repeated episodes (\~15) of breathing low oxygen air to stimulate spinal neuroplasticity. Animal and human studies show that AIH improves motor function after spinal cord injury, particularly with slightly increased carbon dioxide (hypercapnic AIH; AIHH) and task-specific training. Using a double blind cross-over design, the study will test whether AIHH improves breathing more than AIH and whether specific genetic variations are related to individuals' intervention responses.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults 18-70 years of age
Chronic incomplete SCI ≥ 1 year at or below C1-T12
Incomplete SCI based on residual sensory and motor function below the level of the injury or injury classification of B, C, D at initial screening according to the American Spinal Injury Association Impairment Classification and the International Standards for the Neurological Classification of SCI.
Complete SCI based on the absence of residual sensory or motor function below the level of injury or injury classification of A at initial screening according to the American Spinal Injury Association Impairment Classification and the International Standards for the Neurological Classification of SCI.
Disqualifiers
Current diagnosis of an additional neurologic condition such as Multiple Sclerosis, Parkinson disease, stroke, or brain injury
Severe illness or infection, including non-healing decubitus ulcers, untreated bladder or urinary tract infections, cardiovascular disease, lung disease, active heterotopic ossification, or uncontrolled hypertension
Severe neuropathic pain
Known pregnancy
Trial design
Crossover
Treatments tested in this trial
Acute Intermittent Hypoxia (AIH)
Other interventionAIH (acute intermittent hypoxia) consists of short episodes of low oxygen (9% O2).
Acute Intermittent Hypercapnic-Hypoxia (AIHH)
Other interventionAIHH consists of short episodes of low oxygen (9% O2) and elevated carbon dioxide (4% CO2).
Sham AIH
Other interventionA single session of sham AIH with episodes of normal room air (21% O2).
Treatment groups
Trial outcomes
Primary outcomes
Change in motor evoked potential
The change in peak-to-peak amplitude of the motor evoked potential of the diaphragm will be tested using transcranial magnetic stimulation.
Change in maximal inspiratory pressure
Maximal inspiratory pressure is a non-invasive measure of the maximal force achieved when breathing in against an occluded airway.
Change in maximal expiratory pressure
Maximal expiratory pressure is a non-invasive measure of the maximal force achieved when breathing out against an occluded airway.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Florida
Lead sponsor
U.S. Army Medical Research Acquisition Activity
Collaborator